Steven Mintz Age X Therapeutics, Inc. (AGE) insider trading activity

AGE Quotes by TradingView

Steven Mintz is Director of AgeX Therapeutics, Inc.. Currently has a direct ownership of 12,257 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Aug 15, 2024, when has been sold 1,350 shares (Common Stock) at a price of $6.59 per share, resulting in proceeds of $8,896. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.3K
n/a 3M change
n/a 12M change
Total Value Held $0

STEVEN MINTZ Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2024
BUY
Open market or private purchase
$8,896 $6.59 p/Share
1,350 Added 9.92%
12,257 Common Stock
Jun 25 2024
BUY
Open market or private purchase
$23,400 $9.0 p/Share
2,600 Added 19.25%
10,907 Common Stock
Jun 21 2024
BUY
Open market or private purchase
$47,500 $9.5 p/Share
5,000 Added 37.57%
8,307 Common Stock
SM

Steven Mintz

Director
Huntsville, AL

Track Institutional and Insider Activities on AGE

Follow AgeX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGE shares.

Notify only if

Insider Trading

Get notified when an Age X Therapeutics, Inc. insider buys or sells AGE shares.

Notify only if

News

Receive news related to AgeX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGE